BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 14671061)

  • 21. A novel Wilms' tumor 1 gene mutation in a child with severe renal dysfunction and persistent renal blastema.
    Wagner N; Wagner KD; Afanetti M; Nevo F; Antignac C; Michiels JF; Schedl A; Berard E
    Pediatr Nephrol; 2008 Sep; 23(9):1445-53. PubMed ID: 18516627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal transplantation in the management of bilateral Wilms' tumour (BWT) and of Denys-Drash syndrome (DDS).
    Rudin C; Pritchard J; Fernando ON; Duffy PG; Trompeter RS
    Nephrol Dial Transplant; 1998 Jun; 13(6):1506-10. PubMed ID: 9641183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Denys-Drash syndrome.
    Kucinskas L; Rudaitis S; Pundziene B; Just W
    Medicina (Kaunas); 2005; 41(2):132-4. PubMed ID: 15758579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database.
    Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C
    Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WT1 mutations may be a cause of severe renal failure due to nephroblastomatosis in Wilms' tumor patients.
    Santín S; Fraga G; Ruíz P; Pardo N; Torrent M; Martí T; Ballarín J; Ars E; Torra R
    Clin Nephrol; 2011 Sep; 76(3):244-8. PubMed ID: 21888862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infrequent mutation of the WT1 gene in 77 Wilms' Tumors.
    Gessler M; König A; Arden K; Grundy P; Orkin S; Sallan S; Peters C; Ruyle S; Mandell J; Li F
    Hum Mutat; 1994; 3(3):212-22. PubMed ID: 8019557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome.
    Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L
    Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New mutation in WT1 gene in a boy with an incomplete form of Denys-Drash syndrome: A CARE-compliant case report.
    Akramov NR; Shavaliev RF; Osipova IV
    Medicine (Baltimore); 2021 May; 100(19):e25864. PubMed ID: 34106634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
    Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
    Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of Denys-Drash syndrome with prophylactic bilateral nephrectomy].
    Yamamoto K; Santo Y; Satomura K
    Nihon Jinzo Gakkai Shi; 2003; 45(1):42-6. PubMed ID: 12680320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of early onset nephrotic syndrome associated with WT1 missense mutations.
    Schumacher V; Schärer K; Wühl E; Altrogge H; Bonzel KE; Guschmann M; Neuhaus TJ; Pollastro RM; Kuwertz-Bröking E; Bulla M; Tondera AM; Mundel P; Helmchen U; Waldherr R; Weirich A; Royer-Pokora B
    Kidney Int; 1998 Jun; 53(6):1594-600. PubMed ID: 9607189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome.
    Baird PN; Santos A; Groves N; Jadresic L; Cowell JK
    Hum Mol Genet; 1992 Aug; 1(5):301-5. PubMed ID: 1338906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases?
    Schmitt K; Zabel B; Tulzer G; Eitelberger F; Pelletier J
    Eur J Pediatr; 1995 Jul; 154(7):577-81. PubMed ID: 7556327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilateral Wilms' tumor in a child with Denys-Drash syndrome: novel frameshift variant disrupts the WT1 nuclear location signaling region.
    Guaragna MS; Ledesma FL; Manzano VZ; Maciel-Guerra AT; Guerra-Júnior G; Silva MM; Luiz de Brito P; Palandi de Mello M
    J Pediatr Endocrinol Metab; 2022 Jun; 35(6):837-843. PubMed ID: 35304980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline WT1 mutations in Wilms' tumor patients: preliminary results.
    Li FP; Breslow NE; Morgan JM; Ghahremani M; Miller GA; Grundy PE; Green DM; Diller LR; Pelletier J
    Med Pediatr Oncol; 1996 Nov; 27(5):404-7. PubMed ID: 8827066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotype/phenotype correlations in Wilms' tumor.
    Huff V
    Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
    Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
    Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WT1 and glomerular diseases.
    Niaudet P; Gubler MC
    Pediatr Nephrol; 2006 Nov; 21(11):1653-60. PubMed ID: 16927106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited WT1 mutation in Denys-Drash syndrome.
    Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR
    Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome.
    Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J
    FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.